(Q42822258)

8 November 2017

Caspofungin after solid organ transplantation in Germany: observational study on treatment of invasive fungal infections (English)

1 reference

8 November 2017

0 references

organ transplantation

1 reference

invasive fungal infections

inferred from title

1 reference

C Lichtenstern

1

1 reference

8 November 2017

J Pratschke

2

1 reference

8 November 2017

U Schulz

3

1 reference

8 November 2017

M Schmoeckel

4

1 reference

8 November 2017

W Knitsch

5

1 reference

8 November 2017

P Kaskel

6

1 reference

8 November 2017

K J Krobot

7

1 reference

8 November 2017

M A Weigand

8

1 reference

8 November 2017

M Winkler

9

1 reference

8 November 2017

language of work or name

German

0 references

publication date

12 November 2010

1 reference

8 November 2017

1 reference

8 November 2017

59

1 reference

8 November 2017

12

1 reference

8 November 2017

1083-1090

1 reference

https://scigraph.springernature.com/pub.10.1007/s00101-010-1795-6

8 November 2017

0 references

cites work

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://api.crossref.org/works/10.1007%2FS00101-010-1795-6

Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00101-010-1795-6

Echinocandin antifungal drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00101-010-1795-6

Risk factors for invasive aspergillosis in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00101-010-1795-6

Caspofungin as first-line therapy for the treatment of invasive aspergillosis after thoracic organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00101-010-1795-6

Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00101-010-1795-6

Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00101-010-1795-6

Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00101-010-1795-6

Efficacy and safety of amphotericin B lipid complex injection (ABLC) in solid-organ transplant recipients with invasive fungal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00101-010-1795-6

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00101-010-1795-6

Fungal infections in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00101-010-1795-6

Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00101-010-1795-6

Efficacy and safety of caspofungin in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00101-010-1795-6

Amphotericin B with and without itraconazole for invasive aspergillosis: A three-year retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00101-010-1795-6

Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00101-010-1795-6

Caspofungin for post solid organ transplant invasive fungal disease: results of a retrospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00101-010-1795-6

Risk Factors for Invasive Aspergillosis in Solid-Organ Transplant Recipients: A Case-Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00101-010-1795-6

Trends in Risk Profiles for and Mortality Associated with Invasive Aspergillosis among Liver Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00101-010-1795-6

Amphotericin B lipid complex in the treatment of invasive fungal infections: results of the Collaborative Exchange of Antifungal Research (CLEAR), an industry-supported patient registry

21 January 2018

1 reference

12 December 2020

Trends in invasive fungal infections in liver transplant recipients: correlation with evolution in transplantation practices

1 reference

12 December 2020

Antifungal agents for preventing fungal infections in solid organ transplant recipients

1 reference

12 December 2020

Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?

1 reference

12 December 2020

Caspofungin for the treatment of less common forms of invasive candidiasis

1 reference

12 December 2020

Fungal infections in solid organ transplant patients

1 reference

12 December 2020

Fungal infections in solid organ transplantation

1 reference

12 December 2020

Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study1

1 reference

12 December 2020

Invasive candidiasis treated in the intensive care unit: observations from a randomized clinical trial

1 reference

12 December 2020

Antifungal prophylaxis in solid-organ transplant recipients: considerations for clinical trial design.

1 reference

12 December 2020

10.1007/S00101-010-1795-6

Identifiers

DOI

1 reference

8 November 2017

1 reference